Application Nr Approved Date Route Status External Links
ANDA077558 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lamivudine And Zidovudine Tablets, A Combination Of 2 Nucleoside Analogues, Are Indicated In Combination With Other Antiretrovirals For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection. Lamivudine And Zidovudine Tablets, A Combination Of 2 Nucleoside Analogue Reverse Transcriptase Inhibitors, Are Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Lamivudine LAMIVUDINE ZINC12346
2. Zidovudine ZIDOVUDINE ZINC3779042

Comments